Where does Abbott Diagnostics Scarborough, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Abbott Diagnostics Scarborough, Inc. ranks #23,754 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Abbott Diagnostics Scarborough, Inc. hold?

Abbott Diagnostics Scarborough, Inc. holds 11 US utility patents granted between 2021 and 2025, spanning 9 technology areas.

What is Abbott Diagnostics Scarborough, Inc.'s Innovation Score?

Abbott Diagnostics Scarborough, Inc. has an Innovation Score of 43.9 out of 100 (top 27% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Abbott Diagnostics Scarborough, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Abbott Diagnostics Scarborough, Inc..

What does claim depth mean for Abbott Diagnostics Scarborough, Inc.'s patents?

Abbott Diagnostics Scarborough, Inc.'s patents average 19.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Abbott Diagnostics Scarborough, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Abbott Diagnostics Scarborough, Inc.

Q: What technology areas does Abbott Diagnostics Scarborough, Inc. focus on?

Abbott Diagnostics Scarborough, Inc.'s top technology area is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes) with 8 patents, ranking #562 of 2,502 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

USPTO PatentsView assignee record - 11 granted patents across 9 technology areas, recorded in grant years 2021–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Abbott ranks #23,754 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 9 technology areas.

#23,754
of 49,997 US assignees by volume: Top 27%
by Innovation Score (43.9/100): 19.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R23754 · US Corporation #23,754 · 11 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 11 grants
MID-PACK #23,754/49,997
PHOTO-FINISH Abengoa Bioenergy New
CPC-NARROW C12Q · 9 areas
INNOV-PAR 43.9/100
CLAIMS-RICH 19.0 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2021–2025 · 5y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Abengoa Bioenergy New Technologies, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Abbott’s 43.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.6 pts (20%) Velocity 13.3 pts (30%) Breadth 10.6 pts (24%) Claim depth 11.4 pts (26%)

Qualcomm Incorporated · highest

85
Viant AS&O Holdings · near

44
Zibra · near

44
Abbott Diagnostics… · this assignee

44
Illumina Singapore Pte · near

44
Kaistar Lighting(Xia… · near

44
3D Lighting… · lowest

7

What this shows Abbott's Innovation Score is 43.9/100 (top 27% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Abbott?

Each dot is one of Abbott’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Abbott’s own 19.0 claims/patent is ABOVE the 12.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Abbott vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Abbott's grants concentrate

Abbott Diagnostics Scarborough, Inc. is a focused PatentsView assignee: 9 CPC subclasses with 72.7% of grants classified under C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr). Peak complete grant year is 2021 (2 grants) versus a trough of 1 in 2022. By volume, Abbott sits between Avox Systems Inc. and Accessible Technologies, Inc..

Abbott's three-year grant acceleration

Abbott Diagnostics Scarborough, Inc. shows 4 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Avox Systems

11
Awol Outdoors

11
Axim Biotechnolog…

11
AZ

11
Abengoa Bioenergy…

11
Accelerated

11
Access Bio

11
Accessible

11
Abbott Diagnostic… ◀

11

What this shows Abbott holds 11 patents at rank #23,855, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Abbott

By rank, the assignees closest to #23,855 in granted patent volume.

Leaders in C12Q (Measuring OR Testing Processes Involving Enzymes)

Other assignees with the most granted patents in Abbott's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Abbott, neither rank-band nor same-CPC leaders (those blocks stay above). In C12Q (Measuring OR Testing Processes Involving Enzymes), Abbott ranks #562 of 2,502 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (44 here).

Illumina Singapore Pte. Ltd. 44 Kaistar Lighting(Xiamen) Co., Ltd. 44 Viant AS&O Holdings, LLC 44 Zibra, LLC 44

Abbott's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 27% higher than 73% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Abbott Diagnostics Scarborough, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	2	18.2%
2022	1	9.1%
2023	2	18.2%
2024	1	9.1%
2025partial year	5	45.5%

Which technologies does Abbott Diagnostics Scarborough, Inc. patent most?

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 8

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 6

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

C12Y - Enzymes 3

A61J - Containers Specially Adapted FOR Medical OR Pharmaceutical PURPOSES; Devices OR Methods Specially Adapted FOR Bringing Pharmaceutical Products Into Particular Physical OR Administering FORMS; Devices FOR Administering Food OR Medicines ORALLY; Baby COMFORTERS; Devices FOR Receiving Spittle 2

Y10T - Technical Subjects Covered BY Former US Classification 2

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 2

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 2

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Abbott Diagnostics Scarborough, Inc.'s patent record in context - here's where to go next.

Abbott Diagnostics Scarborough, Inc.'s lead technology class is C12Q (Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Micr), 72.7% of its portfolio - see every assignee active in that class. Explore C12Q
Ranked #23,754 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Abbott Diagnostics Scarborough, Inc. against Avox Systems Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 43.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.